Pedro A. de Alarcón

Illinois College — United States

Medicine · Health Sciences

34h-index3.8kcitations136works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(22), Lymphoma Diagnosis and Treatment(19), Hemoglobinopathies and Related Disorders(16), Blood groups and transfusion(15), Platelet Disorders and Treatments(13)

Publications136 total

Dose-dense chemotherapy enables elimination of RT for majority of low-risk pediatric Hodgkin lymphoma: PHC study HOD08
Blood·2026
Impact of the Supreme Court and State Legislation on Pediatric Diversity Initiatives
The Journal of Pediatrics·2026
Latin America (LATAM) Effort to Establish a Trans-Hemispherical Treatment Guideline for Hodgkin Lymphoma (LH)
Klinische Pädiatrie·2025
A RISK ADAPTED, RESPONSE- BASED THERAPEUTIC REGIMEN USING OEPA/COPDAC FOR THE TREATMENT OF CHILDREN WITH HIGH RISK HODGKIN LYMPHOMA; FROM THE AHOPCA GROUP
Klinische Pädiatrie·2025
AML-1178: Trends in Inpatient Outcomes of Adult Acute Myeloid Leukemia in the United States: Impact of Ethnicity and Socioeconomic Status, 2010–2022
Clinical Lymphoma Myeloma & Leukemia·2025
Neolignans isolated from industrial hemp (Cannabis sativa L.) roots have cytotoxic effects on cancer cells
Journal of Cannabis Research·2025Open Access
Metabolic-only response assessment for omission of residual node radiation therapy (RNRT) for patients with classical Hodgkin lymphoma (cHL) and impact on event free (EFS) and overall survival (OS): A report from the Pediatric Hodgkin Consortium’s phase 2 study cHOD17 (NCT03755804).
Journal of Clinical Oncology·2025
Hu14.18K.322A Causes Direct Cell Cytotoxicity and Synergizes with Induction Chemotherapy in High-Risk Neuroblastoma
Cancers·2024· 2 citedOpen Access
Late cognitive and adaptive outcomes of patients with neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia‐syndrome: A report from the Children's Oncology Group
Pediatric Blood & Cancer·2024· 2 citedOpen Access
Abstract 5472: Direct cytotoxicity of hu14.18K.322A in high-risk neuroblastoma
Cancer Research·2024
Pediatric Department Approaches to Promote Diversity, Equity, and Inclusion
The Journal of Pediatrics·2024· 3 citedOpen Access
Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes
Pediatric Blood & Cancer·2023· 4 cited
SARS‐CoV‐2 vaccination response in pediatric oncology patients
Pediatric Blood & Cancer·2023· 8 citedOpen Access
SARS-COV2 VACCINATION RESPONSE IN PEDIATRIC ONCOLOGY PATIENTS
2023Open Access
Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma
Cell Reports·2023· 9 citedOpen Access
Diversity in Pediatrics Department Leadership Positions
The Journal of Pediatrics·2023· 1 citedOpen Access
LUNG STAGING IN PEDIATRIC HODGKIN LYMPHOMA: STAGING EVALUATION & RESPONSE CRITERIA HARMONIZATION FOR CHILDHOOD, ADOLESCENT & YOUNG ADULT HL (SEARCH FOR CAYAHL) CONSENSUS
Hematological Oncology·2023· 5 citedOpen Access
Organizing Committee
2022Open Access
Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer
Cancers·2022· 2 citedOpen Access
Trade-offs between individual and ensemble forecasts of an emerging infectious disease
Nature Communications·2021· 46 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Cindy L. Schwartz(8), Lu Chen(6), Yvan Vandenplas(6), Wendy B. London(5), Louis S. Constine(4), Allen R. Chauvenet(4), Kathleen M. McCarten(4), Gail M. Comer(4), J. L.A. Graeve(4), Cameron K. Tebbi(3), Debra L. Friedman(3), Nancy P. Mendenhall(3), R. Hutchison(3), Pedro Gutiérrez‐Castrellón(3), Stephan D. Voss(3), Richard A. Drachtman(3), Wayne Lam(3), Karen S. Fernández(3), Suzanne L. Wolden(2), Allen Buxton(2)